Skip to main content
SpringerLink
Log in

A Proposal For Italian Guidelines in Pharmacoeconomics

  • Guest Editorial
  • Italian Guidelines in Pharmacoeconomics
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation ofhealth care programmes. Oxford: OxfordUniversity Press, 1987

  2. Rawles J. Castigating QALYS. J Med Ethics 1989; 15: 143–7

    Article  PubMed  CAS  Google Scholar 

  3. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5: 1–30

    Article  PubMed  CAS  Google Scholar 

  4. Pocock SJ. Clinical trials: a practical approach. New York: 10hn Wiley and Sons, 1983

  5. Macrae KD. Pragmatic versus explanatory trials. Int J Technol Assess Health Care 1989; 5: 333–9

    Article  PubMed  CAS  Google Scholar 

  6. Drummond MF, Davies L. Economic analysis alongside clinical trials. Int J Technol Assess Health Care 1991; 7: 561–73

    Article  PubMed  CAS  Google Scholar 

  7. L’Abbe KA, Detsky AS. Meta–analysis in clinical research. Ann Intern Med 1987; 107: 224–33

    PubMed  Google Scholar 

  8. Mooney G. Economics: medicine and health care. London: Harvester Wheatsheaf, 1986

  9. Garattini L. Italian health care reform. York: University of York, 1992

  10. Koopmanschap MA, Rutten FH. Indirect costs in economic studies: confronting the confusion. PharmacoEconomics 1993; 4: 446–54

    Article  PubMed  CAS  Google Scholar 

  11. Katz DA, Welch HG. Discounting in cost–effectiveness analysis of healthcare programmes. PharmacoEconomics 1993; 3: 276–85

    Article  PubMed  CAS  Google Scholar 

  12. Drummond ME Australian guidelines for cost/effectiveness studies of pharmaceuticals: the thin end of the boomerang? Discussion Paper No. 88. York: University ofYork, 1991

    Google Scholar 

  13. Department of Health, Housing and Community Services. Guidelines for the pharmaceutical industry on preparation ofsubmissions to the Pharmaceutical Benefits Advisory Committee. Canberra: Commonwealth of Australia, 1992

  14. Detsky AS. Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada. PharmacoEconomics 1993; 3: 354–61

    Article  PubMed  CAS  Google Scholar 

  15. Ontario Ministry of Health. Guidelines for preparation of economic analysis to be included in submission to drug programsbranch for listing in the Ontario Benefit Formulary/ComparativeDrug Index. Toronto: Ontario Ministry of Health, 1991

  16. Keeler EB, Cretin S. Discounting of life–savings and other nonmonetary effects. Management Sci 1983; 29: 300–6

    Article  Google Scholar 

  17. Weinstein MC, Stason WB. Foundations of cost–effectiveness analysis for health and medicai practices. N Engl J Med 1977; 31: 716–21

    Article  Google Scholar 

  18. Ciocca P, Nardozzi G. L’alto prezzo del denaro. Bari: Laterza Editore, 1993

    Google Scholar 

  19. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivityanalysis. Health Econ 1994; 3: 95–104

    Article  PubMed  CAS  Google Scholar 

  20. Birch S, Gafni A. Cost effectiveness/utility analyses: do current decision rules lead us to where we want to be? J Health Econ 1992; 11: 279–96

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Health Economics, Mario Negri Institute for Pharmacological Research, Villa Camozzi, Via C.B. Camozzi 3, 24020 Ranica (BC), Milan, Italy

    Livio Garattini, Diego Scopelliti & Lorenzo Mantovani

  2. Clinical Epidemiology Laboratory, Mario Negri Institute for Pharmacological Research, Milan, Italy

    Roberto Grilli

Authors
  1. Livio Garattini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberto Grilli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Diego Scopelliti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lorenzo Mantovani
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garattini, L., Grilli, R., Scopelliti, D. et al. A Proposal For Italian Guidelines in Pharmacoeconomics. Pharmacoeconomics 7, 1–6 (1995). https://doi.org/10.2165/00019053-199507010-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199507010-00001

Keywords

Search

Navigation